These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104. Novel pharmacological approaches to the treatment of schizophrenia. Fink-Jensen A Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983 [TBL] [Abstract][Full Text] [Related]
105. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder. Houthoofd SA; Morrens M; Sabbe BG Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365 [TBL] [Abstract][Full Text] [Related]
106. Novel versus conventional antipsychotic drugs. Love RC Pharmacotherapy; 1996; 16(1 Pt 2):6-10. PubMed ID: 8778684 [TBL] [Abstract][Full Text] [Related]
108. Partial compliance in schizophrenia and the impact on patient outcomes. Llorca PM Psychiatry Res; 2008 Nov; 161(2):235-47. PubMed ID: 18849080 [TBL] [Abstract][Full Text] [Related]
109. Evaluating the effects of antipsychotics on cognition in schizophrenia. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998; 59 Suppl 12():35-40. PubMed ID: 9766618 [TBL] [Abstract][Full Text] [Related]
110. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
111. [Therapeutic alliance, a stake in schizophrenia]. Charpentier A; Goudemand M; Thomas P Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998 [TBL] [Abstract][Full Text] [Related]
112. A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia. Bhanji NH; Chouinard G; Margolese HC Eur Neuropsychopharmacol; 2004 Mar; 14(2):87-92. PubMed ID: 15013023 [TBL] [Abstract][Full Text] [Related]